Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) ended the last trading day at $3.08. Company weekly volatility is calculated as 16.73% and price to cash ratio as 1.41. Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) showed a weekly performance of -13.24%.
Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) had its price target trimmed by JMP Securities from $10.00 to $6.00 in a research note issued to investors on Tuesday, Analyst Ratings.Net reports. The brokerage currently has a market outperform rating on the biotechnology company’s stock.
On 20 November, Intel Corporation (NASDAQ:INTC) shares moved up 1.05% and was closed at $34.66. INTC EPS growth in last 5 year was 24.60%. Intel Corporation (NASDAQ:INTC) year to date (YTD) performance is -1.62%.
On 21 November, Intel Corporation (NASDAQ:INTC) said it appointed Murthy Renduchintala as a company president and gave him control of two of its biggest business divisions. Renduchintala, who left Qualcomm Inc. after losing out in a leadership shakeup, will oversee a new unit including Intel’s personal-computer chip and Internet of Things divisions — its biggest source of revenue and one of its fastest-growing businesses, respectively, the company said in a statement.
Alcatel Lucent SA (ADR) (NYSE:ALU) shares moved up 1.52% in last trading session and ended the day at $4.01. ALU Gross Margin is 34.70% and its has a return on assets of -0.70%. Alcatel Lucent SA (ADR) (NYSE:ALU) quarterly performance is 28.12%.
On 19 November, Alcatel Lucent SA (ADR) (NYSE:ALU) joins the ON.Lab organization with an expected focus on virtualized multi-layer IP and optical solutions. The vendor joins ON.Lab’s founding members AT&T, NTT Communications, SK Telecom, China Unicom, Ciena, Cisco, Ericsson, Fujitsu, Huawei, Intel and NEC.
MeetMe, Inc. (NASDAQ:MEET) shares fell -0.40% in last trading session and ended the day at $2.51. MEET has a return on assets of 0.70%. MeetMe, Inc. (NASDAQ:MEET) quarterly performance is 64.05%.
On 16 November, MeetMe, Inc. (NASDAQ:MEET) announced it has been named to Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in North America. Rankings are based on five-year revenue growth. MeetMe grew approximately 319% percent during this period.
Celladon Corporation (NASDAQ:CLDN) caters to the Healthcare space. Its weekly performance is 16.67%. On the last day of trading company shares ended up at $1.26. Celladon Corporation (NASDAQ:CLDN) distance from 50-day simple moving average (SMA50) is 4.90%.
Celladon Corporation (NASDAQ:CLDN) was upgraded by Zacks from a “hold” rating to a “buy” rating in a note issued to investors on Friday, Market Beat Ratings reports.
Leave a Reply